Replies to post #2912 on Sarepta Therapeutics (SRPT)

[r clarke]

FDA getting beat up pretty good.

Last five days have been horrible for SRPT

Also buying below 67

They had decent press a couple weeks ago.

Weird.






"Well....here at 66+ I just bought some more shares. Awful chart don't see anything company specific but most bios and therapeutics are heading down. Couldn't resist but hope I am not too early. Still think the FDA issue with the Alzheimers approval for BIIB is an issue perception wise.

BWDIK....good luck!"

[Atown62]

Same 300 shares today at 67.20

[Atown62]

Here we go again